Skip to main content


News about Memokath™ and Pnn Medical A/S in general will be updated below. For information about congresses and workshops please refer to the Events page.

BAUS 2024 (June 24-26)

Join us right now at stand no. 406 where our highly qualified staff is ready to talk about Memokath.

Closing days in 2024

Pnn Medical A/S is closed the following days:

Thursday 28 March 2024
Friday 29 March 2024
Monday 1 April 2024
Thursday 9 May 2024
Friday 10 May 2024
Monday 20 May 2024
Monday 23 December – Wednesday 1 January 2025

JUA in Japan – April 2024

Our Japanese partner – Kysmaq – will be presenting Memokath during JUA which takes place on 25-27 April in Pacifico Yokohama.

Come an meet us for a chat about why Memokath is the preferred solution.

Our presence in the Asian market

Pnn Medical A/S strengthens its presence in the Asian market as Pnn Medical’s CEO accepts a new position with our Japanese partner.

Casper S. Tvede, CEO of Pnn Medical A/S, has chosen to relocate to Japan to expand the company’s position in the Asian market, with a particular focus on Japan and China, where Pnn Medical A/S anticipates significant growth.

As part of this strategy, Casper has accepted the role of CEO for Pnn’s Japanese partner, Kysmaq. This move supports Pnn Medical’s ambition to enhance its presence in Asia and capitalize on the growing opportunities in the market. Casper possesses in-depth knowledge of the medical field in Asia, especially in Japan, which will be of great benefit to Pnn Medical A/S.

Pnn Medical A/S specializes in the development of urological minimally invasive procedures, including Memokath™, targeting elderly men suffering from BPH (enlarged prostate). The increasing elderly population in Japan and the rest of Asia necessitates the hospital sector to find alternative solutions for cost savings, where Memokath™ plays a significant role.

Kim Brangstrup, Chairman of the Board and owner of Pnn Medical A/S, states:

“We are excited about Casper’s choice, even though it means he will no longer serve as CEO of Pnn Medical A/S. However, this strategic move will strengthen our position in the Asian market and make us a leader in urological implants in Japan and China. I will instead assume the role of CEO of Pnn Medical A/S as of April 1, 2024.”

Casper’s relocation to Japan marks an exciting chapter in Pnn Medical’s history and underscores the company’s commitment to addressing the increasing needs in the Asian market.

Pnn Medical in brief

Pnn Medical A/S was established in Denmark in 1987 to improve the quality of life for people suffering from urinary tract obstructions. Since launch more than 110.000 units of the second-generation urological stent Memokath™ have been inserted worldwide and continue to treat urinary tract obstructions every day.

DUS Denmark in November 2023

Two weeks ago we participated in the annual Danish Urology meeting (DUS) providing positive feed-back from Danish urologists regarding our Memokath stent.

I forrige uge deltog vi i Dansk Urologisk Selskabs årsmøde. Her mødte vi en række danske urologer, og talte om vores Memokath stent.

Endourology Congress Japan – November 2023

Memokath has been presented at the 37th Congress of Japanese Society for Endourology and Robotics in November 2023 by Pnn Medical staff in collaboration with our partner in Japan, Kysmaq.

We look forward to more joint initiatives in 2024. Memokath is currently the preferred solution in Japan.

Chinese Urological Association – October 2023

Memokath has been presented at the annual congress of the Chinese Urological Association in October 2023 by Pnn Medical staff in collaboration with our partner in China, Cheng Lai.

It was a successful congress and Memokath is now one of the leading urological stents in China and the rest of Asia.

Thank you to our customers and partner for making it happen. We look forward to more joint initiatives in 2023 and 2024. Memokath is expected to become the preferred solution in China, as it is in Japan.

Nordkongress – June 2023

Meet us at Nordkongress in Lüneburg right now. 


Vi har lige været med på Kontinensforeningens årlige sommerhøjskole. Du kan finde os via Kontinensforeningens side, eller ved at klikke lige her. Send en e-mail til, hvis du ønsker yderligere oplysninger, råd og vejledning. 

Meet us at booth 414 at the BAUS conference 19 Jun – 21 Jun 2023
Meet us at booth H.415 at the DGU conference 21 Sep – 24 Sep 2022
Memokath 045 article

Have you considered Memokath 045 for the treatment of bladder neck stenosis? No self-catheterisation or surgery is necessary and a study out of University College London Hospitals NHS FT published promising results with 93% of patients remaining fully continent a minimum of 12 months post stent removal. Read the article here.

Memokath™ workshop in Dubai

A successful Memokath™ workshop took place at the end of January during the Arab Health Dubai 2022.

Our next workshop will take place in the UK in April. To participate please send an email

Memokath Workshop in Dubai

Next Memokath™ workshop in April 2022

Again we are hosting live workshops so please check our EVENTS section for the next workshop.

Memokath™ workshop Webinars

Until further notice our workshops are replaced by webinars due to the worldwide COVID-19 situation. Check our EVENTS section for the next webinar.

New direct setup in France

After more than 15 years of cooperation with BD Bard (formerly known as C.R. Bard), Pnn Medical has decided to enter the French market with our own sales force from February 1st 2019. France has been an important market for MemokathTM historically and we look forward to building

First ever Memokath™ inserted in Canada

Last week the first ever Memokath™ stent was inserted in Canada, at the McGill University Hospital in Montreal. The case: After four years of self-catheterization following an obstructed UroLume stent inserted in 2015, the 70-year old patient was treated with Memokath™ 045 TW Urethra